A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. [electronic resource]
Producer: 20200902Description: 5148-5157 p. digitalISSN:- 2045-7634
- Adult
- Aged
- Aged, 80 and over
- Albumins -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers
- Deoxycytidine -- administration & dosage
- Disease Management
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Molecular Targeted Therapy
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Prognosis
- Receptor, Notch2 -- antagonists & inhibitors
- Receptor, Notch3 -- antagonists & inhibitors
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.